Results 31 to 40 of about 16,792 (294)
Emollient product design: objective measurements of formulation structure, texture and performance, and subjective assessments of user acceptability [PDF]
, 2018 Background: The choice of prescribed emollients is usually based on cost and patient preference. Differences in formulations can affect user acceptability.
Ashton +20 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Although most malignant germ cell tumors (GCTs) are highly curable with cisplatin‐based therapy, options for patients with multiply relapsed/refractory disease remain limited. For this population, we report the first pediatric use of gemcitabine, docetaxel, melphalan, and carboplatin (GemDMC) as part of sequential cycles of high‐dose ...
Maria Frost +10 more
wiley +1 more source
Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison
Pharmaceutics, 2021 Many dermatological conditions, such as eczema and psoriasis, are treated with topical therapeutic products. Instead of applying the active drug directly onto the skin, it is combined with a vehicle to aid in its delivery across the stratum corneum (SC ...
Tanya M. Barnes +4 more
doaj +1 more source
Diagnosis, assessment and treatment of childhood eczema in primary care:cross-sectional study [PDF]
, 2017 Background: The majority of children with eczema in the UK are looked after in primary care yet we know little about their care in this setting. Aim: To compare the diagnosis, assessment, and treatment of eczema in primary care with published diagnostic ...
Garfield, Kirsty +3 more
core +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background/Objectives Outcomes for pediatric relapsed/refractory (R/R) acute myeloid leukemia (AML) remain dismal. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, may have less off‐target toxicities than traditional chemotherapies and has shown improved outcomes for adults with newly diagnosed therapy‐related AML.
Jonathan D. Bender +17 more
wiley +1 more source
A Clinical Investigation of the Performance and Safety of Epaderm®, an Emollient Cream [Corrigendum]
Clinical, Cosmetic and Investigational Dermatology, 2021 August S, Granier S, Tighe MP, Tbaily LW, Ahlbom H. Clin Cosmet Investig Dermatol. 2021;14:909–920. The authors have advised the author list on page 909 is incorrect. The correct author list and affiliations are as follows. Suzannah August1 Stephen
August S +4 more
doaj
Frontiers in Sustainability, 2023 IntroductionCopoazú seed butter [Theobroma grandiflorum (Wild ex Spreng) K. Schum] is a rich source of fatty acids and polyphenols, active substances with high antioxidant and moisturizing activities with potential applications in the cosmetic industry ...
Chabely M. Aparicio-Álvarez +2 more
doaj +1 more source
, 2007 A distressed mother attends the clinic with her three year old daughter, who developed an itchy rash. The rash is reddish and affects her face and wrists. The child is restless and has been scratching all night.
Formosa, Marie Claire
core
Cochrane Database of Systematic Reviews, 2010 Reason for withdrawal from publication This protocol has been withdrawn as the team relinquished the title. A new review has been published by a new team: van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen A, Arents BWM. Emollients and moisturisers for eczema. Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD012119.
Oranje, Arnold P. +5 more
openaire +4 more sources
Novel filagrinol-containing emollient
Vestnik dermatologii i venerologii, 2022 Background. In the last decade, there has been a significant increase in interest in the study of the role of epidermal barrier structural integrity in order to determine the prospects for its pathogenetic correction. It is now known that patients with filaggrin gene mutations have increased risk of developing atopic dermatitis, xerosis, ichthyosis ...
Elena S. Snarskaya, Anna V. Bratkovskaya
openaire +1 more source